In contrast, inhibition of copper transporter protein attenuated α-synuclein-mediated pathological changes in Parkinson’s patients and reduced the increase in proteogenic fibrillation and oxidative stress (Davies et al., 2014; Gou et al., 2021). Here, SNCA is linked to Parkinson disease.